Developing vaccines to prevent malaria in pregnant women

Bibliography

• Miller LH, Baruch DI, Marsh K, et al. The pathogenic basis of malaria. Nature 2002;415:673-9
   PubMed Web of Science ®Google Scholar
• Tembo D, Montgomery J. Var gene expression and human Plasmodium pathogenesis. Future Microbiol 2010;5:801-15
   PubMed Web of Science ®Google Scholar
• Coppel RL, Brown GV, Nussenzweig V. Adhesive proteins of the malaria parasite. Curr Opin Microbiol 1998;1:472-81
   PubMed Web of Science ®Google Scholar
• Rask TS, Hansen DA, Theander TG, et al. Plasmodium falciparum erythrocyte membrane protein 1 diversity in seven genomes--divide and conquer. PLoS Comput Biol 2010;6:e1000933
   Google Scholar
• Smith JD. The role of Pfemp1 adhesion domain classification in Plasmodium falciparum pathogenesis research. Mol Biochem Parasitol 2014;195:82-7
   PubMed Web of Science ®Google Scholar
• Hviid L. Naturally acquired immunity to Plasmodium falciparum malaria in Africa. Acta Trop 2005;95:270-5
   PubMed Web of Science ®Google Scholar
• Dellicour S, Tatem AJ, Guerra CA, et al. Quantifying the number of pregnancies at risk of malaria in 2007: a demographic study. PLoS Med 2010;7:e1000221
   PubMed Web of Science ®Google Scholar
• Muthusamy A, Achur RN, Bhavanandan VP, et al. Plasmodium falciparum-infected erythrocytes adhere both in the intervillous space and on the villous surface of human placenta by binding to the low-sulfated chondroitin sulfate proteoglycan receptor. Am J Pathol 2004;164:2013-25
   PubMed Web of Science ®Google Scholar
• Fried M, Duffy PE. Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta. Science 1996;272:1502-4
   PubMed Web of Science ®Google Scholar
• Cot M, Deloron P. Malaria prevention strategies. Br Med Bull 2003;67:137-48
   PubMed Web of Science ®Google Scholar
• Brabin BJ, Romagosa C, Abdelgalil S, et al. The sick placenta-the role of malaria. Placenta 2004;25:359-78
   PubMed Web of Science ®Google Scholar
• Desai M, ter Kuile FO, Nosten F, et al. Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis 2007;7:93-104
   PubMed Web of Science ®Google Scholar
• Hartman TK, Rogerson SJ, Fischer PR. The impact of maternal malaria on newborns. Ann Trop Paediatr 2010;30:271-82
   PubMed Web of Science ®Google Scholar
• Le Hesran JY, Cot M, Personne P, et al. Maternal placental infection with Plasmodium falciparum and malaria morbidity during the first 2 years of life. Am J Epidemiol 1997;146:826-31
   PubMed Web of Science ®Google Scholar
• Mutabingwa TK, Bolla MC, Li JL, et al. Maternal malaria and gravidity interact to modify infant susceptibility to malaria. PLoS Med 2005;2:e407
   PubMed Web of Science ®Google Scholar
• Schwarz NG, Adegnika AA, Breitling LP, et al. Placental malaria increases malaria risk in the first 30 months of life. Clin Infect Dis 2008;47:1017-25
   PubMed Web of Science ®Google Scholar
• WHO. World Malaria Report 2014; 2014
   Google Scholar
• Brabin BJ. An analysis of malaria in pregnancy in Africa. Bull World Health Organ 1983;61:1005-16
   PubMed Web of Science ®Google Scholar
• McGregor IA, Wilson ME, Billewicz WZ. Malaria infection of the placenta in The Gambia, West Africa; its incidence and relationship to stillbirth, birthweight and placental weight. Trans R Soc Trop Med Hyg 1983;77:232-44
   PubMed Web of Science ®Google Scholar
• Duffy PE, Fried M. Antibodies that inhibit Plasmodium falciparum adhesion to chondroitin sulfate A are associated with increased birth weight and the gestational age of newborns. Infect Immun 2003;71:6620-3
   PubMed Web of Science ®Google Scholar
• Parise ME, Ayisi JG, Nahlen BL, et al. Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. Am J Trop Med Hyg 1998;59:813-22
   PubMed Web of Science ®Google Scholar
• ter Kuile FO, van Eijk AM, Filler SJ. Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review. Jama 2007;297:2603-16
   PubMed Web of Science ®Google Scholar
• Kayentao K, Kodio M, Newman RD, et al. Comparison of intermittent preventive treatment with chemoprophylaxis for the prevention of malaria during pregnancy in Mali. J Infect Dis 2005;191:109-16
   PubMed Web of Science ®Google Scholar
• Shulman CE, Dorman EK, Cutts F, et al. Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo- controlled trial. Lancet 1999;353:632-6
   PubMed Web of Science ®Google Scholar
• Malaria Policy Advisory Committee to the WHO. Conclusions and recommendations of September 2013. Malar J 2013;12:456
   PubMedGoogle Scholar
• WHO. The World Health Report 2005 - make every mother and child count 2005
   Google Scholar
• Alker AP, Kazadi WM, Kutelemeni AK, et al. Dhfr and dhps genotype and sulfadoxine- pyrimethamine treatment failure in children with falciparum malaria in the Democratic Republic of Congo. Trop Med Int Health 2008;13:1384-91
   PubMed Web of Science ®Google Scholar
• Aubouy A, Jafari S, Huart V, et al. DHFR and DHPS genotypes of Plasmodium falciparum isolates from Gabon correlate with in vitro activity of pyrimethamine and cycloguanil, but not with sulfadoxine-pyrimethamine treatment efficacy. J Antimicrob Chemother 2003;52:43-9
   PubMed Web of Science ®Google Scholar
• Faucher JF, Aubouy A, Adeothy A, et al. Comparison of sulfadoxine-pyrimethamine, unsupervised artemether-lumefantrine, and unsupervised artesunate-amodiaquine fixed-dose formulation for uncomplicated Plasmodium falciparum malaria in Benin: a randomized effectiveness noninferiority trial. J Infect Dis 2009;200:57-65
   PubMed Web of Science ®Google Scholar
• Gesase S, Gosling RD, Hashim R, et al. High resistance of Plasmodium falciparum to sulphadoxine/pyrimethamine in northern Tanzania and the emergence of dhps resistance mutation at Codon 581. PLoS ONE 2009;4:e4569
   PubMed Web of Science ®Google Scholar
• Tekete M, Djimde AA, Beavogui AH, et al. Efficacy of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria: revisiting molecular markers in an area of emerging AQ and SP resistance in Mali. Malar J 2009;8:34
   PubMed Web of Science ®Google Scholar
• Malaria Policy Advisory Committee to the WHO. Conclusions and recommendations of September 2013 meeting. Malar J 2013;12:456
   PubMedGoogle Scholar
• WHO. World Malria Report 2013
   Google Scholar
• Deloron P, Bertin G, Briand V, et al. Sulfadoxine/pyrimethamine intermittent preventive treatment for malaria during pregnancy. Emerg Infect Dis 2010;16:1666-70
   PubMed Web of Science ®Google Scholar
• Huynh BT, Cottrell G, Cot M, Briand V. Burden of malaria in early pregnancy: a neglected problem? Clin Infect Dis 2015;60:598-604
   PubMed Web of Science ®Google Scholar
• Doritchamou J, Bertin G, Moussiliou A, et al. First-trimester Plasmodium falciparum infections display a typical ‘placental’ phenotype. J Infect Dis 2012;206:1911-19
   PubMed Web of Science ®Google Scholar
• Cottrell G, Moussiliou A, Luty AJ, et al. Submicroscopic Plasmodium falciparum infections are associated with maternal anemia, premature births and low birthweight. Clin Infect Dis 2015;60(10):1481-8
   PubMed Web of Science ®Google Scholar
• Doritchamou J, Sossou-tchatcha S, Cottrell G, et al. Dynamics in the cytoadherence phenotypes of Plasmodium falciparum infected erythrocytes isolated during pregnancy. PLoS ONE 2014;9:e98577
   Google Scholar
• Salanti A, Dahlback M, Turner L, et al. Evidence for the involvement of VAR2CSA in pregnancy-associated malaria. J Exp Med 2004;200:1197-203
   PubMed Web of Science ®Google Scholar
• Salanti A, Staalsoe T, Lavstsen T, et al. Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malaria. Mol Microbiol 2003;49:179-91
   PubMed Web of Science ®Google Scholar
• Tuikue Ndam NG, Salanti A, Bertin G, et al. High level of var2csa transcription by Plasmodium falciparum isolated from the placenta. J Infect Dis 2005;192:331-5
   PubMed Web of Science ®Google Scholar
• Viebig NK, Levin E, Dechavanne S, et al. Disruption of var2csa gene impairs placental malaria associated adhesion phenotype. PLoS One 2007;2:e910
   Google Scholar
• Viebig NK, Gamain B, Scheidig C, et al. A single member of the Plasmodium falciparum var multigene family determines cytoadhesion to the placental receptor chondroitin sulphate A. EMBO Rep 2005;6:775-81
   PubMed Web of Science ®Google Scholar
• Bockhorst J, Lu F, Janes JH, et al. Structural polymorphism and diversifying selection on the pregnancy malaria vaccine candidate VAR2CSA. Mol Biochem Parasitol 2007;155:103-12
   PubMed Web of Science ®Google Scholar
• Gamain B, Trimnell AR, Scheidig C, et al. Identification of multiple chondroitin sulfate A (CSA)-binding domains in the var2CSA gene transcribed in CSA-binding parasites. J Infect Dis 2005;191:1010-13
   PubMed Web of Science ®Google Scholar
• Avril M, Gamain B, Lepolard C, et al. Characterization of anti-var2CSA-PfEMP1 cytoadhesion inhibitory mouse monoclonal antibodies. Microbes Infect 2006;8:2863-71
   PubMed Web of Science ®Google Scholar
• Bir N, Yazdani SS, Avril M, et al. Immunogenicity of Duffy binding-like domains that bind chondroitin sulfate A and protection against pregnancy-associated malaria. Infect Immun 2006;74:5955-63
   PubMed Web of Science ®Google Scholar
• Gowda AS, Madhunapantula SV, Achur RN, et al. Structural basis for the adherence of Plasmodium falciparum-infected erythrocytes to chondroitin 4-sulfate and design of novel photoactivable reagents for the identification of parasite adhesive proteins. J Biol Chem 2007;282:916-28
   PubMed Web of Science ®Google Scholar
• Higgins MK. The structure of a chondroitin sulfate-binding domain important in placental malaria. J Biol Chem 2008;283:21842-6
   PubMed Web of Science ®Google Scholar
• Singh K, Gittis AG, Nguyen P, et al. Structure of the DBL3x domain of pregnancy-associated malaria protein VAR2CSA complexed with chondroitin sulfate A. Nat Struct Mol Biol 2008;15:932-8
   PubMed Web of Science ®Google Scholar
• Singh K, Gitti RK, Diouf A, et al. Subdomain 3 of Plasmodium falciparum VAR2CSA DBL3x is identified as a minimal chondroitin sulfate A-binding region. J Biol Chem 2010;285:24855-62
   PubMed Web of Science ®Google Scholar
• Khunrae P, Dahlback M, Nielsen MA, et al. Full-length recombinant Plasmodium falciparum VAR2CSA binds specifically to CSPG and induces potent parasite adhesion-blocking antibodies. J Mol Biol 2010;397:826-34
   PubMed Web of Science ®Google Scholar
• Srivastava A, Durocher Y, Gamain B. Expressing full-length functional PfEMP1 proteins in the HEK293 expression system. Methods Mol Biol 2013;923:307-19
   PubMedGoogle Scholar
• Ataide R, Mayor A, Rogerson SJ. Malaria, primigravidae, and antibodies: knowledge gained and future perspectives. Trends Parasitol 2014;30:85-94
   PubMed Web of Science ®Google Scholar
• O’Neil-Dunne I, Achur RN, Agbor-Enoh ST, et al. Gravidity-dependent production of antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to placental chondroitin sulfate proteoglycan during pregnancy. Infect Immun 2001;69:7487-92
   PubMed Web of Science ®Google Scholar
• Tuikue Ndam NG, Salanti A, Le-Hesran JY, et al. Dynamics of anti-VAR2CSA immunoglobulin G response in a cohort of senegalese pregnant women. J Infect Dis 2006;193:713-20
   PubMed Web of Science ®Google Scholar
• Agnandji ST, Lell B, Soulanoudjingar SS, et al. First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. N Engl J Med 2011;365:1863-75
   PubMed Web of Science ®Google Scholar
• Hviid L. The case for PfEMP1-based vaccines to protect pregnant women against Plasmodium falciparum malaria. Expert Rev Vaccines 2011;10:1405-14
   PubMed Web of Science ®Google Scholar
• Bull PC, Lowe BS, Kortok M, et al. Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria. Nat Med 1998;4:358-60
   PubMed Web of Science ®Google Scholar
• Fried M, Nosten F, Brockman A, et al. Maternal antibodies block malaria. Nature 1998;395:851-2
   PubMed Web of Science ®Google Scholar
• Duffy PE, Fried M. Malaria during pregnancy: parasites, antibodies and chondroitin sulphate A. Biochem Soc Trans 1999;27:478-82
   PubMed Web of Science ®Google Scholar
• Tuikue Ndam NG, Fievet N, Bertin G, et al. Variable adhesion abilities and overlapping antigenic properties in placental Plasmodium falciparum isolates. J Infect Dis 2004;190:2001-9
   PubMed Web of Science ®Google Scholar
• Strategies TO Prevent Pregnancy-Associated Malaria (STOPPAM). Available from: http://cordis.europa.eu/result/rcn/53959_fr.html [Last accessed 2 May 2015]
   Google Scholar
• Huynh BT, Fievet N, Gbaguidi G, et al. Influence of the timing of malaria infection during pregnancy on birth weight and on maternal anemia in Benin. Am J Trop Med Hyg 2011;85:214-20
   PubMed Web of Science ®Google Scholar
• Tuikue Ndam N, Denoeud-Ndam L, Doritchamou J, et al. Protective antibodies against placental malaria and poor outcomes during pregnancy, Benin. Emerg Infect Dis 2015;21:813-23
   PubMed Web of Science ®Google Scholar
• Avril M, Hathaway MJ, Srivastava A, et al. Antibodies to a full-length VAR2CSA immunogen are broadly strain-transcendent but do not cross-inhibit different placental-type parasite isolates. PLoS One 2011;6:e16622
   PubMed Web of Science ®Google Scholar
• Doritchamou J, Bigey P, Nielsen MA, et al. Differential adhesion-inhibitory patterns of antibodies raised against two major variants of the NTS-DBL2X region of VAR2CSA. Vaccine 2013;31:4516-22
   PubMed Web of Science ®Google Scholar
• Bigey P, Gnidehou S, Doritchamou J, et al. The NTS-DBL2X region of VAR2CSA induces cross-reactive antibodies that inhibit adhesion of several Plasmodium falciparum isolates to chondroitin sulfate A. J Infect Dis 2011;204:1125-33
   PubMed Web of Science ®Google Scholar
• Bordbar B, Gnidehou S, Ndam NT, et al. Electroporation-mediated genetic vaccination for antigen mapping application to Plasmodium falciparum VAR2CSA protein. Bioelectrochemistry 2012;87:132-7
   PubMed Web of Science ®Google Scholar
• Bordbar B, Tuikue-Ndam N, Bigey P, et al. Identification of Id1-DBL2X of VAR2CSA as a key domain inducing highly inhibitory and cross-reactive antibodies. Vaccine 2012;30:1343-8
   PubMed Web of Science ®Google Scholar
• Dahlback M, Jorgensen LM, Nielsen MA, et al. The chondroitin sulfate A-binding site of the VAR2CSA protein involves multiple N-terminal domains. J Biol Chem 2011;286:15908-17
   PubMed Web of Science ®Google Scholar
• Srivastava A, Gangnard S, Round A, et al. Full-length extracellular region of the var2CSA variant of PfEMP1 is required for specific, high-affinity binding to CSA. Proc Natl Acad Sci USA 2010;107:4884-9
   PubMed Web of Science ®Google Scholar
• Clausen TM, Christoffersen S, Dahlback M, et al. Structural and functional insight into how the Plasmodium falciparum VAR2CSA protein mediates binding to chondroitin sulfate A in placental malaria. J Biol Chem 2012;287:23332-45
   PubMed Web of Science ®Google Scholar
• Nielsen MA, Pinto VV, Resende M, et al. Induction of adhesion-inhibitory antibodies against placental Plasmodium falciparum parasites by using single domains of VAR2CSA. Infect Immun 2009;77:2482-7
   PubMed Web of Science ®Google Scholar
• Babakhanyan A, Leke RG, Salanti A, et al. The antibody response of pregnant Cameroonian women to VAR2CSA ID1-ID2a, a small recombinant protein containing the CSA-binding site. PLoS ONE 2014;9:e88173
   Google Scholar
• Placental Malaria Vaccine (PlacMalVac). Available from: http://cmp.ku.dk/collaborations/placmalvac/ [Last accessed 2 May 2015]
   Google Scholar
• PRIMALVAC. Available from: http://www.euvaccine.eu/portfolio/project-index/primalvac [Last accessed 2 May 2015]
   Google Scholar
• Lavstsen T, Turner L, Saguti F, et al. Plasmodium falciparum erythrocyte membrane protein 1 domain cassettes 8 and 13 are associated with severe malaria in children. Proc Natl Acad Sci USA 2012;109:E1791-800
   PubMed Web of Science ®Google Scholar
• Bertin GI, Lavstsen T, Guillonneau F, et al. Expression of the domain cassette 8 Plasmodium falciparum erythrocyte membrane protein 1 is associated with cerebral malaria in Benin. PLoS ONE 2013;8:e68368
   Google Scholar
• Teo A, Hasang W, Randall LM, et al. Decreasing malaria prevalence and its potential consequences for immunity in pregnant women. J Infect Dis 2014;210:1444-55
   PubMed Web of Science ®Google Scholar
• Jaworowski A, Fernandes LA, Yosaatmadja F, et al. Relationship between human immunodeficiency virus type 1 coinfection, anemia, and levels and function of antibodies to variant surface antigens in pregnancy-associated malaria. Clin Vaccine Immunol 2009;16:312-19
   PubMed Web of Science ®Google Scholar
• Feng G, Aitken E, Yosaatmadja F, et al. Antibodies to variant surface antigens of Plasmodium falciparum-infected erythrocytes are associated with protection from treatment failure and the development of anemia in pregnancy. J Infect Dis 2009;200:299-306
   PubMed Web of Science ®Google Scholar
• Ataíde R, Mwapasa V, Molyneux ME, et al. Antibodies that induce phagocytosis of malaria infected erythrocytes: effect of HIV infection and correlation with clinical outcomes. PLoS ONE 2011;6:e22491
   Google Scholar
• Keen J, Serghides L, Ayi K, et al. HIV impairs opsonic phagocytic clearance of pregnancy-associated malaria parasites. PLoS Med 2007;4:e181
   PubMed Web of Science ®Google Scholar
• Lambert LH, Bullock JL, Cook ST, et al. Antigen reversal identifies targets of opsonizing IgGs against pregnancy-associated malaria. Infect Immun 2014;82:4842-53
   PubMed Web of Science ®Google Scholar
• Gbedande K, Cottrell G, Ibitokou S, et al. Cytokine response to the VAR2CSA vaccine candidate in pregnant Benineese. Am J Trop Med Hyg 2014;91:S475
   Google Scholar
• Ampomah P, Stevenson L, Ofori MF, et al. B-cell responses to pregnancy-restricted and - unrestricted Plasmodium falciparum erythrocyte membrane protein 1 antigens in Ghanaian women naturally exposed to malaria parasites. Infect Immun 2014;82:1860-71
   PubMed Web of Science ®Google Scholar
• Ampomah P, Stevenson L, Ofori MF, et al. Kinetics of B cell responses to Plasmodium falciparum erythrocyte membrane protein 1 in Ghanaian women naturally exposed to malaria parasites. J Immunol 2014;192:5236-44
   PubMed Web of Science ®Google Scholar
• Guitard J, Andersen P, Ermont C, et al. Plasmodium falciparum population dynamics in a cohort of pregnant women in Senegal. Malar J 2010;9:165
   PubMedGoogle Scholar
• Sander AF, Salanti A, Lavstsen T, et al. Multiple var2csa-type PfEMP1 genes located at different chromosomal loci occur in many Plasmodium falciparum isolates. PLoS ONE 2009;4:e6667
   PubMed Web of Science ®Google Scholar
• Agnandji ST, Lell B, Fernandes JF, et al. A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. N Engl J Med 2012;367:2284-95
   PubMed Web of Science ®Google Scholar
• Olotu A, Fegan G, Wambua J, et al. Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure. N Engl J Med 2013;368:111-20
   Google Scholar